• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER; CATHETER, CONTINUOUS FLUSH Back to Search Results
Catalog Number 500-56112
Device Problems Occlusion Within Device (1423); Failure to Deliver (2338)
Patient Problem Therapeutic Response, Decreased (2271)
Event Date 04/19/2016
Event Type  malfunction  
Manufacturer Narrative
The therapy did not resolve the clot on the right side, therefore this is a reportable event.Having the clot remain, increases the risk of further pulmonary events in this patient.Two levels of investigation was performed - microscopic and functional.A microscopic review revealed the presence of blood in the drug lumen.The returned complaint sample appeared to have been aspirated with a syringe from all ports.Moderate difficulty was encountered while flushing from the drug port during the functional evaluation.The ifu directs users against blood draw procedures through the drug lumen.The root cause of this event therefore appears to be use/user related.
 
Event Description
Customer contacted the ekos helpline at the beginning of a bilateral pulmonary embolism (pe) case reporting an alarm on the right lung drug port pump.Hospital staff flushed the catheter using 4 x w/1cc syringe and the pump was restarted.After 10.5 hours the pump alarmed due to a downstream occlusion.Flushing was performed, with resistance noted.The pump pressure was increased to 'maximum' however the pump continued to alarm.The physician stopped the administration of the tissue plasminogen activator (tpa) to the right lung and continued the coolant through the catheter.Post cessation of the ekos therapy the physician attempted to extract the clot using penumbra, however no clot was aspirated.The physician deemed that the right lung clot was a 'chronic clot'(verbatim).The reporter stated that the patient 'did well' (verbatim) with therapy, with the left lung reported as 'mostly clear of clot'(verbatim).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC ENDOVASCULAR CATHETER
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
EKOS CORPORATION
11911 north creek parkway s
bothell WA 98011 8809
Manufacturer (Section G)
EKOS CORPORATION
11911 north creek parkway s.
bothell WA 98011 8809
Manufacturer Contact
benjamin hornsey
11911 north creek parkway s
bothell, WA 98011-8809
4254153143
MDR Report Key5671217
MDR Text Key45700373
Report Number3001627457-2016-00013
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140151
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/23/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/25/2018
Device Catalogue Number500-56112
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/26/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/20/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/25/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-